Capsula Informátiva Ralstonia
Octubre 2025
1. Alshuhri, S., Alosaimi, A., Aldhlawi, Z.,
Althawadi, S., Alghamdi, S., & Aljumaah, S. (2025). Ralstonia
mannitolilytica infection in a tertiary care center: An outbreak
report. American journal of infection control, 53(3), 302–307.
https://doi.org/10.1016/j.ajic.2024.09.019.
2.Aquino-Andrade
A, Mérida-Vieyra J, Lara-Hernández A, Hernández-Orozco H, De
Colsa-Ranero A. Tipificación de aislamientos de Ralstonia mannito
lilytica en un hospital pediátrico de la Ciudad de México. Acta Pediatr
Méx 2022; 43 (2): 73-8.
3. Kano, Y.,
& Kikuchi, K. (2023). Ralstonia mannitolilytica Bacteremia Stemming
From Frequent Outpatient Intravenous Injections at a Local Clinic.
Cureus, 15(10), e47887. https://doi.org/10.7759/cureus.47887.
4. Kim, G., Yoo,
R. N., So, H., Lee, J. Y., Kim, M. N., Kim, S. H., Jhang, W. K., Park,
S. J., & Lee, J. (2023). Clinical Manifestation of Ralstonia
mannitolilytica Infection in Pediatric Patients and Epidemiological
Investigation of Outbreaks. Journal of Korean medical science, 38(33),
e252. https://doi.org/10.3346/jkms.2023.38.e252.
5. Prieto, M.
F., Lebym, L., Vallory, L., Servicio de Farmacia, & Servicio de
Enfermería. (2025). Outbreak of Ralstonia mannitolilytica in
immunocompromised patients associated with a contaminated drug.
Pharmacy & Pharmacology International Journal, 13(3).
https://medcraveonline.com/PPIJ/PPIJ-13-00469.pdf
6. Siddiqui, T.,
Patel, S. S., Sinha, R., Ghoshal, U., & Sahu, C. (2022). Ralstonia
mannitolilytica: an emerging multidrug-resistant opportunistic pathogen
in a tertiary care hospital setting. Access microbiology, 4(5),
acmi000367. https://doi.org/10.1099/acmi.0.000367.